Additionally, it was observed that the silencing of MICALL2 prevented the activation of canonical wnt/beta-catenin signaling and induced mesenchymal–epithelial transition (MET) in ovarian cancer cells [10]. This evidence concerns the gene MICALL2 and ovarian carcinoma.